These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19926054)

  • 1. Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis.
    Brown JR; Block CA; Malenka DJ; O'Connor GT; Schoolwerth AC; Thompson CA
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1116-24. PubMed ID: 19926054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of contrast-induced acute kidney injury in patients with stable chronic renal disease undergoing elective percutaneous coronary and peripheral interventions: randomized comparison of two preventive strategies.
    Hafiz AM; Jan MF; Mori N; Shaikh F; Wallach J; Bajwa T; Allaqaband S
    Catheter Cardiovasc Interv; 2012 May; 79(6):929-37. PubMed ID: 21542114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In search of an algorithm to prevent acute kidney injury.
    Dauerman HL
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1125-7. PubMed ID: 19926055
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of short-term infusion regimens of N-acetylcysteine plus intravenous fluids, sodium bicarbonate plus intravenous fluids, and intravenous fluids alone for prevention of contrast-induced nephropathy in the emergency department.
    Kama A; Yılmaz S; Yaka E; Dervişoğlu E; Doğan NÖ; Erimşah E; Pekdemir M
    Acad Emerg Med; 2014 Jun; 21(6):615-22. PubMed ID: 25039544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.
    Keach JW; Stanislawski MA; Barón AE; Plomondon ME; Langner P; Amin A; Gilmartin HM; Waldo S; Maddox TM
    BMC Nephrol; 2020 Apr; 21(1):150. PubMed ID: 32345254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?
    Heng AE; Cellarier E; Aublet-Cuvelier B; Decalf V; Motreff P; Marcaggi X; Deteix P; Souweine B
    Clin Nephrol; 2008 Dec; 70(6):475-84. PubMed ID: 19049703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.
    Thayssen P; Lassen JF; Jensen SE; Hansen KN; Hansen HS; Christiansen EH; Junker A; Ravkilde J; Thuesen L; Veien KT; Jensen LO
    Circ Cardiovasc Interv; 2014 Apr; 7(2):216-24. PubMed ID: 24714489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.
    Weisbord SD; Gallagher M; Kaufman J; Cass A; Parikh CR; Chertow GM; Shunk KA; McCullough PA; Fine MJ; Mor MK; Lew RA; Huang GD; Conner TA; Brophy MT; Lee J; Soliva S; Palevsky PM
    Clin J Am Soc Nephrol; 2013 Sep; 8(9):1618-31. PubMed ID: 23660180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
    Briguori C; Visconti G; Ricciardelli B; Condorelli G;
    EuroIntervention; 2011 Apr; 6(9):1117-22, 7. PubMed ID: 21518686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.
    Ma WQ; Zhao Y; Wang Y; Han XQ; Zhu Y; Liu NF
    Int Urol Nephrol; 2018 Jun; 50(6):1085-1095. PubMed ID: 29404930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
    Zhao SJ; Zhong ZS; Qi GX; Tian W
    Int J Cardiol; 2016 Oct; 221():251-9. PubMed ID: 27404685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine.
    Weisbord SD; Gallagher M; Jneid H; Garcia S; Cass A; Thwin SS; Conner TA; Chertow GM; Bhatt DL; Shunk K; Parikh CR; McFalls EO; Brophy M; Ferguson R; Wu H; Androsenko M; Myles J; Kaufman J; Palevsky PM;
    N Engl J Med; 2018 Feb; 378(7):603-614. PubMed ID: 29130810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do intravenous N-acetylcysteine and sodium bicarbonate prevent high osmolal contrast-induced acute kidney injury? A randomized controlled trial.
    Inda-Filho AJ; Caixeta A; Manggini M; Schor N
    PLoS One; 2014; 9(9):e107602. PubMed ID: 25254489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of contrast-induced nephropathy: a single center randomized study.
    Castini D; Lucreziotti S; Bosotti L; Salerno Uriarte D; Sponzilli C; Verzoni A; Lombardi F
    Clin Cardiol; 2010 Mar; 33(3):E63-8. PubMed ID: 20127900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials.
    Wu MY; Hsiang HF; Wong CS; Yao MS; Li YW; Hsiang CY; Bai CH; Hsu YH; Lin YF; Tam KW
    Int Urol Nephrol; 2013 Oct; 45(5):1309-18. PubMed ID: 23283594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney Biomarkers of Injury and Repair as Predictors of Contrast-Associated AKI: A Substudy of the PRESERVE Trial.
    Parikh CR; Liu C; Mor MK; Palevsky PM; Kaufman JS; Thiessen Philbrook H; Weisbord SD
    Am J Kidney Dis; 2020 Feb; 75(2):187-194. PubMed ID: 31547939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial.
    Chong E; Poh KK; Lu Q; Zhang JJ; Tan N; Hou XM; Ong HY; Azan A; Chen SL; Chen JY; Ali RM; Fang WY; Lau TW; Tan HC
    Int J Cardiol; 2015 Dec; 201():237-42. PubMed ID: 26301645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
    Navaneethan SD; Singh S; Appasamy S; Wing RE; Sehgal AR
    Am J Kidney Dis; 2009 Apr; 53(4):617-27. PubMed ID: 19027212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness of 12 Treatment Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-analysis.
    Su X; Xie X; Liu L; Lv J; Song F; Perkovic V; Zhang H
    Am J Kidney Dis; 2017 Jan; 69(1):69-77. PubMed ID: 27707552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography.
    Schmidt P; Pang D; Nykamp D; Knowlton G; Jia H
    Ann Pharmacother; 2007 Jan; 41(1):46-50. PubMed ID: 17190844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.